Stock Price
6.00
Daily Change
-0.22 -3.54%
Monthly
105.48%
Yearly
-57.42%
Q2 Forecast
5.96

Plus Therapeutics reported $-4.4M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Baxter International USD -447M 873M Dec/2025
Dr.Reddys Laboratories INR 20.89B 117M Dec/2025
Haemonetics USD 115.53M 9.22M Sep/2025
Infinity Pharmaceuticals USD -10.01M 1.39M Jun/2023
Northwest Biotherapeutics USD -13.41M 232K Sep/2023
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Sanofi EUR 3.31B 3.65B Mar/2026
Starpharma Holdings AUD -4.85M 1.73M Dec/2024
Sun Pharmaceuticals INR 49.48B 8.52B Dec/2025
Teva Pharmaceutical Industries USD 1.06B 582M Mar/2026